Literature DB >> 1327567

In vitro enhancement of fluoropyrimidine-induced cytotoxicity by leucovorin in colorectal and gastric carcinoma cell lines but not in non-small-cell lung carcinoma cell lines.

Y Sugimoto1, Y Ohe, K Nishio, T Ohmori, Y Fujiwara, N Saijo.   

Abstract

Leucovorin (LV) increases the cytotoxic effect of fluorouracil (FUra) and 5-fluoro-2'-deoxyuridine (FdUrd) by enhancing the formation of the fluorodeoxyuridine monophosphate (FdUMP) thymidylate synthase (TS) 5,10-methylenetetrahydrofolate (mTHF) ternary complex. To study the difference in the efficacy of this combination against different tumors, we compared the effect of LV (20 microM) on the cytotoxicity of FUra, FdUrd, and 5-fluorouridine (FUrd) in vitro against cell lines of five colorectal carcinomas (CC), five gastric carcinomas (GC), and four non-small-cell lung carcinomas (NSCLC) using the colony-forming assay. At the concentration used in the experiments, LV alone failed to inhibit colony formation in any of the cell lines tested. The NSCLC cell lines were more resistant to FdUrd than were the CC and GC lines. LV modulated the cytotoxicity of FdUrd in all five CC lines and in three of the five GC lines but failed to do so in any of the NSCLC lines. In addition, following 20 h treatment with 1 microM [3H]-FdUrd, formation of the FdUMP/TS/mTHF ternary complex was enhanced by LV in the LV-sensitized CC and GC cell lines but not in the LV-refractory NSCLC lines. These in vitro data corresponded well to the results of clinical trials. Therefore, the colony-forming assay may be useful for the identification of the sensitivity of tumors according to phenotype.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1327567     DOI: 10.1007/bf00685591

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN: 0344-5704            Impact factor:   3.333


  42 in total

1.  Studies on fluorinated pyrimidines. V. Effects on nucleic acid metabolism in vitro.

Authors:  L BOSCH; E HARBERS; C HEIDELBERGER
Journal:  Cancer Res       Date:  1958-04       Impact factor: 12.701

2.  Effect of excess folates and deoxyinosine on the activity and site of action of 5-fluorouracil.

Authors:  R M Evans; J D Laskin; M T Hakala
Journal:  Cancer Res       Date:  1981-09       Impact factor: 12.701

3.  In vitro evaluation of the new anticancer agents KT6149, MX-2, SM5887, menogaril, and liblomycin using cisplatin- or adriamycin-resistant human cancer cell lines.

Authors:  Y Ohe; K Nakagawa; Y Fujiwara; Y Sasaki; K Minato; M Bungo; S Niimi; N Horichi; M Fukuda; N Saijo
Journal:  Cancer Res       Date:  1989-08-01       Impact factor: 12.701

Review 4.  Biochemical modulation of fluorouracil: evidence of significant improvement of survival and quality of life in patients with advanced colorectal carcinoma.

Authors:  M A Poon; M J O'Connell; C G Moertel; H S Wieand; S A Cullinan; L K Everson; J E Krook; J A Mailliard; J A Laurie; L K Tschetter
Journal:  J Clin Oncol       Date:  1989-10       Impact factor: 44.544

5.  Biochemical determinants of tumor sensitivity to 5-fluorouracil: ultrasensitive methods for the determination of 5-fluoro-2'-deoxyuridylate, 2'-deoxyuridylate, and thymidylate synthetase.

Authors:  R G Moran; C P Spears; C Heidelberger
Journal:  Proc Natl Acad Sci U S A       Date:  1979-03       Impact factor: 11.205

6.  A randomized trial of fluorouracil and folinic acid in patients with metastatic colorectal carcinoma.

Authors:  C Erlichman; S Fine; A Wong; T Elhakim
Journal:  J Clin Oncol       Date:  1988-03       Impact factor: 44.544

7.  Role of folylpolyglutamates in biochemical modulation of fluoropyrimidines by leucovorin.

Authors:  A Romanini; J T Lin; D Niedzwiecki; M Bunni; D G Priest; J R Bertino
Journal:  Cancer Res       Date:  1991-02-01       Impact factor: 12.701

8.  Thymidylate synthetase levels as a factor in 5-fluorodeoxyuridine and methotrexate cytotoxicity in gastrointestinal tumor cells.

Authors:  W L Washtien
Journal:  Mol Pharmacol       Date:  1982-05       Impact factor: 4.436

9.  A naturally occurring variation in thymidylate synthase structure is associated with a reduced response to 5-fluoro-2'-deoxyuridine in a human colon tumor cell line.

Authors:  S H Berger; K W Barbour; F G Berger
Journal:  Mol Pharmacol       Date:  1988-10       Impact factor: 4.436

10.  Mechanism of the cytotoxic synergism of fluoropyrimidines and folinic acid in mouse leukemic cells.

Authors:  K Keyomarsi; R G Moran
Journal:  J Biol Chem       Date:  1988-10-05       Impact factor: 5.157

View more
  2 in total

1.  Mismatch repair proficiency and in vitro response to 5-fluorouracil.

Authors:  J M Carethers; D P Chauhan; D Fink; S Nebel; R S Bresalier; S B Howell; C R Boland
Journal:  Gastroenterology       Date:  1999-07       Impact factor: 22.682

Review 2.  New targets for pyrimidine antimetabolites in the treatment of solid tumours. 1: Thymidylate synthase.

Authors:  C L van der Wilt; G J Peters
Journal:  Pharm World Sci       Date:  1994-04-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.